Advertisement
Advertisement

MPLT

M

MapLight Therapeutics, Inc. Common Stock

18.60
USD
Sponsored
-0.26
-1.37%
Jan 29, 16:00 UTC -5
Closed
exchange

After-Market

18.65

+0.05
+0.26%

MPLT Earnings Reports

Positive Surprise Ratio

MPLT beat 0 of 1 last estimates.

0%

Next Report

Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.01
Implied change from Q3 25 (Revenue/ EPS)
--
/
-97.28%
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

MapLight Therapeutics, Inc. Common Stock earnings per share and revenue

On Dec 04, 2025, MPLT reported earnings of -37.18 USD per share (EPS) for Q3 25, missing the estimate of -1.75 USD, resulting in a -2013.10% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -1.01 USD, with revenue projected to reach -- USD, implying an decrease of -97.28% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, MapLight Therapeutics, Inc. Common Stock reported EPS of -$37.18, missing estimates by -2013.1%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.83%, changed from $17.19 before the earnings release to $18.02 the day after.
The next earning report is scheduled for Mar 02, 2026.
Based on -- analysts, MapLight Therapeutics, Inc. Common Stock is expected to report EPS of -$1.01 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement